Diagrow Exim Private Limited - Company Profile

It is a consumer goods private limited company based in Mumbai, Maharashtra, India, established in 2014.
2014 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Diagrow Exim Private Limited

Diagrow Exim Private Limited, a active private limited company, was established on 21 March 2014 in Mumbai, Maharashtra, India. Engaging in watches & jewelry manufacturing within the trade sector, it holds CIN: U36932MH2014PTC254818. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Nilay Mukesh Jogani (Director), Kunal Vasantlal Shah (Director). Past directors included Hema Chetan Shah, Sarthak Chetan Shah. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 503, 5Th Floor, Kheni Tower, Cts -4919 To 4944, Manipada Road, Santac, Ruz-East, Mumbai, Maharashtra, 400098.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U36932MH2014PTC254818

  • Registration Number

    254818

  • Incorporation Date

    21 March 2014

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 11 Year, 10 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** 27491.18%
  • Profit Growth **** 4180.59%
  • Ebitda **** 856.16%
  • Net Worth 22.30%
  • Total Assets **** 1559.84%
Company report

Diagrow Exim Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Diagrow Exim Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Diagrow Exim Private Limited?
Current Directors
Name Designation Appointment Date Status
Nilay Mukesh Jogani Director 13 May 2016 Current
Kunal Vasantlal Shah Director 30 Mar 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 13 May 2016 Past
Pramod Abcsdd Director 30 Mar 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Diagrow Exim.

Diagrow Exim Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 27491.18% increase. The company also saw a substantial improvement in profitability, with a 4180.59% increase in profit. The company's net worth Soared by an impressive increase of 22.3%.

Diagrow Exim revenue growth over time
Diagrow Exim profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 27491.18%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 1559.84%
*******
*******
*******
*******
Profit or Loss
*******
 4180.59%
*******
*******
*******
*******
Net Worth
*******
 22.30%
*******
*******
*******
*******
EBITDA
*******
 856.16%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Diagrow Exim?

In 2018, Diagrow Exim had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Diagrow Exim?

Unlock and access historical data on people associated with Diagrow Exim, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Diagrow Exim, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Diagrow Exim's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Diagrow Exim
Recent Activity within the Organization
  • Annual General Meeting

    Diagrow Exim Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Diagrow Exim Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.

  • Director Appointment

    The activity Kunal Vasantlal Shah was appointed as a Director was appointed as a Director on 30 Mar 2021 & has been associated with this company since 4 years 10 months . was completed.

  • Director Appointment

    Progress on Nilay Mukesh Jogani was appointed as a Director was appointed as a Director on 13 May 2016 & has been associated with this company since 9 years 9 months . was documented.

  • Company Incorporation

    Diagrow Exim Private Limited was registered on 21 Mar 2014 with Roc Mumbai & aged 11 years 10 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Diagrow Exim Private Limited?

The CIN of Diagrow Exim Private Limited is U36932MH2014PTC254818.

Where is Diagrow Exim Private Limited headquartered?

Diagrow Exim Private Limited is headquartered at 503, 5Th Floor, Kheni Tower, Cts -4919 To 4944, Manipada Road, Santac, Ruz-East, Mumbai, Maharashtra, 400098.

When was Diagrow Exim Private Limited incorporated?

Diagrow Exim Private Limited was incorporated on 21 March 2014.

Who are the current directors of Diagrow Exim Private Limited?

The current directors of Diagrow Exim Private Limited are

What is the primary industry of Diagrow Exim Private Limited?

The primary industry of Diagrow Exim Private Limited is Trade.

Is Diagrow Exim Private Limited a listed company?

Diagrow Exim Private Limited is unlisted.

What is the capital structure of Diagrow Exim Private Limited?

The authorized capital of Diagrow Exim Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Diagrow Exim Private Limited?

The compliance status of Diagrow Exim Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available